深静脉介入术后最佳药物治疗:SIR基金会研究共识专家组会议纪要
SIR基金会召集多学科专家召开虚拟研究共识专家组会议,针对深静脉介入术后抗血栓治疗制定优先研究议程。专家组依据临床相关性、整体影响和技术可行性对研究优先事项进行排序,确定了四个高优先级研究方向:支架内狭窄/再血栓形成的生物学过程、静脉血流动力学评估方法的验证、炎症及抗炎治疗的作用、以及抗血栓策略比较与静脉结局评估的临床研究。
要点
- 深静脉介入术后最佳药物治疗方案尚不明确,抗血栓策略缺乏高质量证据。
- 支架内狭窄/再血栓形成机制、静脉血流动力学评估及炎症作用是重点研究方向。
- 需多中心协作研究比较抗血栓策略并改进静脉结局评估。
临床应用与阅片要点
- 关注深静脉介入术后抗血栓治疗的研究进展,目前尚无明确推荐方案。
- 支架内狭窄/再血栓形成机制、静脉血流动力学评估和炎症作用是未来研究方向。
- 静脉结局评估方法需进一步验证以指导临床决策。
局限性
- 会议为专家共识性质,未提供系统评价或原始研究数据。
- 研究议程基于专家讨论和排序,可能存在主观性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The optimal medical management of patients following endovascular deep venous interventions remains ill-defined. As such, the Society of Interventional Radiology Foundation (SIRF) convened a multidisciplinary group of experts in a virtual Research Consensus Panel (RCP) to develop a prioritized research agenda regarding antithrombotic therapy following deep venous interventions. The panelists presented the gaps in knowledge followed by discussion and ranking of research priorities based on clinical relevance, overall impact, and technical feasibility. The following research topics were identified as high priority: 1) characterization of biological processes leading to in-stent stenosis/rethrombosis; 2) identification and validation of methods to assess venous flow dynamics and their effect on stent failure; 3) elucidation of the role of inflammation and anti-inflammatory therapies; and 4) clinical studies to compare antithrombotic strategies and improve venous outcome assessment. Collaborative, multicenter research is necessary to answer these questions and thereby enhance the care of patients with venous disease.
引用
- Khaja MS, Obi AT, Sharma AM, et al. Optimal Medical Therapy Following Deep Venous Interventions: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel. J Vasc Interv Radiol. 2021. PMID: 34563699. doi:10.1016/j.jvir.2021.09.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。